Abstract Introduction
Introduction
The geko™ device, designed for thromboprophylaxis, has been demonstrated to improve venous, arterial and microcirculatory flow, in healthy volunteers. It is hypothesised that similar effects may be seen in arteriopaths. This study aimed to establish the haemodynamic efficacy of this device in such patients.
Methods
Following ethical approval patients were recruited from the outpatients department. After a 30 minute acclimatisation period, bilateral baseline arterial, venous and microcirculatory flow (Laser Doppler) measurements were taken. The device was applied for 60 minutes, unilaterally, and flow measurements repeated. The difference in flow from baseline was calculated and statistical analysis performed. 
Conclusion
Transcutaneous electrical neuromuscular stimulation with the geko™ device augments arterial, venous and microcirculatory flow in peripheral arterial disease patients and may prove a useful treatment adjunct in these patients.
